Cargando…

Photodynamic Therapy (PDT) with Chemotherapy for Advanced Lung Cancer with Airway Stenosis

Intractable advanced lung cancer can be treated palliatively with photodynamic therapy (PDT) combined with chemotherapy to remove central and peripheral (lobar or segmental bronchi) bronchial stenosis and obstruction. We present data for 12 (eight men, four women) consecutive patients with 13 advanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimura, Masakazu, Miyajima, Kuniharu, Kojika, Masakazu, Kono, Takafumi, Kato, Harubumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632810/
https://www.ncbi.nlm.nih.gov/pubmed/26512656
http://dx.doi.org/10.3390/ijms161025466
_version_ 1782399101946560512
author Kimura, Masakazu
Miyajima, Kuniharu
Kojika, Masakazu
Kono, Takafumi
Kato, Harubumi
author_facet Kimura, Masakazu
Miyajima, Kuniharu
Kojika, Masakazu
Kono, Takafumi
Kato, Harubumi
author_sort Kimura, Masakazu
collection PubMed
description Intractable advanced lung cancer can be treated palliatively with photodynamic therapy (PDT) combined with chemotherapy to remove central and peripheral (lobar or segmental bronchi) bronchial stenosis and obstruction. We present data for 12 (eight men, four women) consecutive patients with 13 advanced non-small cell lung carcinomas in whom curative operations were contraindicated, who underwent PDT combined with chemotherapy for local control of the intraluminal lesions. The mean age was 73.3 years (range, 58–80 years), and the stages of cancer were IIA–IV. The median stenosis rates before treatment, one week post-treatment, and one month post-treatment were 60% (range, 30%–100%), 15% (range, 15%–99%), and 15% (range 15%–60%), respectively. The mean and median survival times were 9.3 and 5.9 months, respectively. The overall 1-year survival rate was 30.0%. No PDT-related morbidity or mortality occurred. In this single-institution study, all patients experienced improved symptoms and quality of life at one week after treatment; furthermore, an objective response was evidenced by the substantial increase in the openings of the bronchial lumen and prevention of obstructive pneumonia. Therefore, PDT with chemotherapy was useful and safe for the treatment of bronchial obstruction.
format Online
Article
Text
id pubmed-4632810
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-46328102015-11-23 Photodynamic Therapy (PDT) with Chemotherapy for Advanced Lung Cancer with Airway Stenosis Kimura, Masakazu Miyajima, Kuniharu Kojika, Masakazu Kono, Takafumi Kato, Harubumi Int J Mol Sci Article Intractable advanced lung cancer can be treated palliatively with photodynamic therapy (PDT) combined with chemotherapy to remove central and peripheral (lobar or segmental bronchi) bronchial stenosis and obstruction. We present data for 12 (eight men, four women) consecutive patients with 13 advanced non-small cell lung carcinomas in whom curative operations were contraindicated, who underwent PDT combined with chemotherapy for local control of the intraluminal lesions. The mean age was 73.3 years (range, 58–80 years), and the stages of cancer were IIA–IV. The median stenosis rates before treatment, one week post-treatment, and one month post-treatment were 60% (range, 30%–100%), 15% (range, 15%–99%), and 15% (range 15%–60%), respectively. The mean and median survival times were 9.3 and 5.9 months, respectively. The overall 1-year survival rate was 30.0%. No PDT-related morbidity or mortality occurred. In this single-institution study, all patients experienced improved symptoms and quality of life at one week after treatment; furthermore, an objective response was evidenced by the substantial increase in the openings of the bronchial lumen and prevention of obstructive pneumonia. Therefore, PDT with chemotherapy was useful and safe for the treatment of bronchial obstruction. MDPI 2015-10-23 /pmc/articles/PMC4632810/ /pubmed/26512656 http://dx.doi.org/10.3390/ijms161025466 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kimura, Masakazu
Miyajima, Kuniharu
Kojika, Masakazu
Kono, Takafumi
Kato, Harubumi
Photodynamic Therapy (PDT) with Chemotherapy for Advanced Lung Cancer with Airway Stenosis
title Photodynamic Therapy (PDT) with Chemotherapy for Advanced Lung Cancer with Airway Stenosis
title_full Photodynamic Therapy (PDT) with Chemotherapy for Advanced Lung Cancer with Airway Stenosis
title_fullStr Photodynamic Therapy (PDT) with Chemotherapy for Advanced Lung Cancer with Airway Stenosis
title_full_unstemmed Photodynamic Therapy (PDT) with Chemotherapy for Advanced Lung Cancer with Airway Stenosis
title_short Photodynamic Therapy (PDT) with Chemotherapy for Advanced Lung Cancer with Airway Stenosis
title_sort photodynamic therapy (pdt) with chemotherapy for advanced lung cancer with airway stenosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632810/
https://www.ncbi.nlm.nih.gov/pubmed/26512656
http://dx.doi.org/10.3390/ijms161025466
work_keys_str_mv AT kimuramasakazu photodynamictherapypdtwithchemotherapyforadvancedlungcancerwithairwaystenosis
AT miyajimakuniharu photodynamictherapypdtwithchemotherapyforadvancedlungcancerwithairwaystenosis
AT kojikamasakazu photodynamictherapypdtwithchemotherapyforadvancedlungcancerwithairwaystenosis
AT konotakafumi photodynamictherapypdtwithchemotherapyforadvancedlungcancerwithairwaystenosis
AT katoharubumi photodynamictherapypdtwithchemotherapyforadvancedlungcancerwithairwaystenosis